Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.5.0.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2016
Jul. 29, 2016
Document And Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2016  
Entity Registrant Name NAVIDEA BIOPHARMACEUTICALS, INC.  
Trading Symbol NAVB  
Entity Central Index Key 0000810509  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q2  
Entity Filer Category Accelerated Filer  
Entity Common Stock, Shares Outstanding   155,751,316